Abstract

The persistence of immunogenicity in patients with immune-mediated inflammatory diseases (IMID) on disease-modifying antirheumatic therapy (DMARD) has been less well studied. This extension study evaluates the SARS-CoV2 antibody decay kinetics...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
P696 Genetic predisposition to infliximab immunogenicity in patients with immune-mediated inflammatory diseases – secondary analyses from a randomised clinical trial
K Bjørlykke ... G E Stenvik
Journal of Crohn's and Colitis | VOL. 16
K Bjørlykke, et. al.K Bjørlykke ... G E Stenvik
21 Jan 2022
Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis
Anuraag Jena ... Shaji Sebastian
Autoimmunity reviews | VOL. 21
Anuraag Jena, et. al.Anuraag Jena ... Shaji Sebastian
30 Aug 2021
P529 Evolution of COVID19 serology in a real-life population of IMID patients. Results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)
J Geldof ... M Ferrante
Journal of Crohn's and Colitis | VOL. 16
J Geldof, et. al.J Geldof ... M Ferrante
21 Jan 2022
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
Markus Cornberg ... Daniel Shouval
Journal of Hepatology | VOL. 74
Markus Cornberg, et. al.Markus Cornberg ... Daniel Shouval
06 Feb 2021
View more papers

More From: RMD Open

Paper Title
Journal
Date
Author
Bridging the gap: facilitating the use of rheumatology research results in clinical practice with hybrid implementation effectiveness studies
Leti Van Bodegom-Vos ... Theodora P M Vliet Vlieland
RMD Open | VOL. 10
Leti Van Bodegom-Vos, et. al.Leti Van Bodegom-Vos ... Theodora P M Vliet Vlieland
08 Jul 2024
Are poor prognostic factors a realistic basis for treatment decisions in patients with rheumatoid arthritis? Lessons from the IMPROVED study
Joy Ardjuna Van Der Pol ... Sytske Anne Bergstra
RMD Open | VOL. 10
Joy Ardjuna Van Der Pol, et. al.Joy Ardjuna Van Der Pol ... Sytske Anne Bergstra
21 Jun 2024
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus
Yurie Satoh-Kanda ... Yoshiya Tanaka
RMD Open | VOL. 10
Yurie Satoh-Kanda, et. al.Yurie Satoh-Kanda ... Yoshiya Tanaka
13 Jun 2024
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis
Manouk De Hooge ... Sofia Ramiro
RMD Open | VOL. 10
Manouk De Hooge, et. al.Manouk De Hooge ... Sofia Ramiro
08 Jun 2024
View more papers